Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Can blood gene expression predict which patients with multiple sclerosis will respond to interferon?

PLoS medicine - 1 Feb 2005

Kaminski Naftali, Achiron Anat

Abstract excerpt

No abstract is available from the source.

Topics

Join the communities discussing this publication.

Adjuvants, Immunologic
Gene Expression Profiling
Interferon-beta
Leukocytes, Mononuclear
Multiple Sclerosis
Predictive Value of Tests
Prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 15736992
DOI: 10.1371/journal.pmed.0020033
PMCID: PMC549584

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Can blood gene expression predict which patients with multiple sclerosis will respond to interferon?PMID 15736992Read ↗

Interferon-beta therapy in multiple sclerosis: the short-term and long-term effects on the patients’ individual gene expression in peripheral bloodSemantic proximity Read ↗

A gene expression study denies the ability of 25 candidate biomarkers to predict the interferon-beta treatment response in multiple sclerosis patientsSemantic proximity Read ↗

Peripheral blood gene expression signature mirrors central nervous system disease: The model of multiple sclerosisSemantic proximity Read ↗

Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patientsSemantic proximity Read ↗

Gene-expression signatures: biomarkers toward diagnosing multiple sclerosisSemantic proximity Read ↗

Blood transcriptional signatures of multiple sclerosis: Unique gene expression of disease activitySemantic proximity Read ↗

Expression profiling identifies responder and non-responder phenotypes to interferon-beta in multiple sclerosis.Semantic proximity Read ↗

Pharmacogenomic analysis of interferon receptor polymorphisms in multiple sclerosisSemantic proximity Read ↗

Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to diseaseSemantic proximity Read ↗

T cell gene expression profiling identifies distinct subgroups of Japanese multiple sclerosis patientsSemantic proximity Read ↗

Pharmacogenomics and multiple sclerosis: moving toward individualized medicine.Semantic proximity Read ↗

Expression Analysis of Long Non-coding RNAs in the Blood of Multiple Sclerosis PatientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.